
Malgorzata A. Walicka
Examiner (ID: 315)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 345 |
| Issued Applications | 187 |
| Pending Applications | 28 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18127911
[patent_doc_number] => 11554106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of miochondrial origin
[patent_app_type] => utility
[patent_app_number] => 16/492546
[patent_app_country] => US
[patent_app_date] => 2018-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4437
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492546 | Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of miochondrial origin | Mar 6, 2018 | Issued |
Array
(
[id] => 15589615
[patent_doc_number] => 20200071342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => VOLTAGE SENSITIVE DYES
[patent_app_type] => utility
[patent_app_number] => 16/490467
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16490467
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/490467 | Voltage sensitive dyes | Mar 1, 2018 | Issued |
Array
(
[id] => 18932281
[patent_doc_number] => 11884687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Boronated multifunctional targeting drug conjugates, their uses and methods for their preparation
[patent_app_type] => utility
[patent_app_number] => 16/489884
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 12109
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489884
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489884 | Boronated multifunctional targeting drug conjugates, their uses and methods for their preparation | Feb 28, 2018 | Issued |
Array
(
[id] => 12880387
[patent_doc_number] => 20180185304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/906350
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15906350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/906350 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | Feb 26, 2018 | Abandoned |
Array
(
[id] => 16169441
[patent_doc_number] => 10710989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Method for producing heterocyclic compound
[patent_app_type] => utility
[patent_app_number] => 16/488770
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 25315
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488770
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488770 | Method for producing heterocyclic compound | Feb 26, 2018 | Issued |
Array
(
[id] => 13870601
[patent_doc_number] => 20190031641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => PYRAZOLE DERIVATIVES AS SGC STIMULATORS
[patent_app_type] => utility
[patent_app_number] => 15/902708
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15902708
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/902708 | PYRAZOLE DERIVATIVES AS SGC STIMULATORS | Feb 21, 2018 | Abandoned |
Array
(
[id] => 13371711
[patent_doc_number] => 20180237396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => Processes For Preparing AG-10, Its Intermediates, and Salts Thereof
[patent_app_type] => utility
[patent_app_number] => 15/932327
[patent_app_country] => US
[patent_app_date] => 2018-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -74
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15932327
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/932327 | Process for preparing AG-10, its intermediates, and salts thereof | Feb 15, 2018 | Issued |
Array
(
[id] => 16999379
[patent_doc_number] => 11078169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide
[patent_app_type] => utility
[patent_app_number] => 16/490480
[patent_app_country] => US
[patent_app_date] => 2018-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7583
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16490480
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/490480 | Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide | Feb 15, 2018 | Issued |
Array
(
[id] => 16999379
[patent_doc_number] => 11078169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide
[patent_app_type] => utility
[patent_app_number] => 16/490480
[patent_app_country] => US
[patent_app_date] => 2018-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7583
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16490480
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/490480 | Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide | Feb 15, 2018 | Issued |
Array
(
[id] => 15178059
[patent_doc_number] => 20190359621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => BICYCLIC UREA COMPOUNDS AND THEIR USE AS SOLVENT
[patent_app_type] => utility
[patent_app_number] => 16/481105
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481105
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481105 | BICYCLIC UREA COMPOUNDS AND THEIR USE AS SOLVENT | Feb 8, 2018 | Abandoned |
Array
(
[id] => 16970399
[patent_doc_number] => 11066359
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Biodegradable surfactants and related compositions, methods and systems
[patent_app_type] => utility
[patent_app_number] => 16/484817
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 35
[patent_no_of_words] => 32711
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 454
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484817
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484817 | Biodegradable surfactants and related compositions, methods and systems | Feb 7, 2018 | Issued |
Array
(
[id] => 13777877
[patent_doc_number] => 20190002477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/885333
[patent_app_country] => US
[patent_app_date] => 2018-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15885333
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/885333 | ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | Jan 30, 2018 | Abandoned |
Array
(
[id] => 16549693
[patent_doc_number] => 10882842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Pyridinium compounds, a synthesis method therefor, metal or metal alloy plating baths containing said pyridinium compounds and a method for use of said metal or metal alloy plating baths
[patent_app_type] => utility
[patent_app_number] => 16/483053
[patent_app_country] => US
[patent_app_date] => 2018-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10657
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 356
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483053
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483053 | Pyridinium compounds, a synthesis method therefor, metal or metal alloy plating baths containing said pyridinium compounds and a method for use of said metal or metal alloy plating baths | Jan 25, 2018 | Issued |
Array
(
[id] => 16222642
[patent_doc_number] => 20200247758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => Therapeutic Inhibitors of the Reverse Mode of ATP Synthase
[patent_app_type] => utility
[patent_app_number] => 16/478497
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478497
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/478497 | Therapeutic inhibitors of the reverse mode of ATP synthase | Jan 16, 2018 | Issued |
Array
(
[id] => 17539912
[patent_doc_number] => 11305016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Vitamin D3 and analogs thereof for treating alopecia
[patent_app_type] => utility
[patent_app_number] => 15/872669
[patent_app_country] => US
[patent_app_date] => 2018-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 52
[patent_no_of_words] => 30212
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15872669
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/872669 | Vitamin D3 and analogs thereof for treating alopecia | Jan 15, 2018 | Issued |
Array
(
[id] => 16512862
[patent_doc_number] => 20200392120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => NOVEL PREPARATION CONTAINING BENZIMIDAZOLE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/473748
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473748
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/473748 | Preparation containing benzimidazole derivative | Dec 25, 2017 | Issued |
Array
(
[id] => 16704311
[patent_doc_number] => 10954231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Anxiolytic compounds
[patent_app_type] => utility
[patent_app_number] => 15/844264
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14947
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15844264
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/844264 | Anxiolytic compounds | Dec 14, 2017 | Issued |
Array
(
[id] => 14057795
[patent_doc_number] => 10233181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Anxiolytic compounds
[patent_app_type] => utility
[patent_app_number] => 15/844295
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14797
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 350
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15844295
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/844295 | Anxiolytic compounds | Dec 14, 2017 | Issued |
Array
(
[id] => 12640962
[patent_doc_number] => 20180105485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => CYCLIC VINYLOGOUS AMIDES AS BROMODOMAIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/842032
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47860
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15842032
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/842032 | Cyclic vinylogous amides as bromodomain inhibitors | Dec 13, 2017 | Issued |
Array
(
[id] => 13397409
[patent_doc_number] => 20180250247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/821371
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821371
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821371 | N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | Nov 21, 2017 | Abandoned |